Asieris Pharmaceuticals was founded in March 2010, with the goal of establishing a globally recognized research and development company for innovative drugs. Asieris Pharmaceuticals focus is on making breakthroughs in the field of cancer treatment through internal research and collaborations with institutions. Asieris Pharmaceuticals has gained preliminary evidence of clinical efficacy from clinical research in China and is preparing to advance the new drug development to the global market.